Biogen to buy the retinal gene-therapy maker Nightstar
Monday, May 27, 2019 - 21:06
in Mathematics & Economics
The $800 million purchase is the third gene-therapy acquisition announced in a week
The $800 million purchase is the third gene-therapy acquisition announced in a week